NetworkNewsBreaks – Genprex, Inc. (NASDAQ: GNPX) Reports Preclinical Data Showing Positive Results for Treatment of Resistant Metastatic Lung Cancers

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company, today announced that its collaborators from The University of Texas MD Anderson Cancer Center (“MD Anderson”) presented positive preclinical data at the American Association of Cancer Research Tumor Immunology and Immunotherapy Meeting 2019. According to the update, the data shows positive results for the combination of TUSC2 immunogene therapy with an anti-PD1 antibody, pembrolizumab, and for the combination of TUSC2 immunogene therapy, pembrolizumab, and chemotherapy for the treatment of some of the most resistant metastatic lung cancers, including the KRAS and LKB1 mutations. “These data not only further support existing preclinical data showing that Oncoprex immunogene therapy is synergistic with anti-PD1 therapy, but they also offer new data demonstrating that Oncoprex improves on the combination of anti-PD1 therapy and chemotherapy, today’s first line standard of care for lung cancer,” Genprex President and Chief Operating Officer Julien L. Pham, MD, MPH, said in the news release. “In a sophisticated humanized mouse model, the combination of TUSC2 with pembrolizumab and carboplatin resulted in complete eradication of anti-PD1 resistant lung metastases in some of the most resistant cancer mutations. This is highly encouraging and provides us with a strong indication that the combination could lead to similar results in the clinic.”

To view the full press release, visit http://nnw.fm/flRk2

About Genprex, Inc.

Genprex, Inc. is a clinical stage gene therapy company developing potentially life-changing technologies for cancer patients based upon a unique proprietary technology platform. Genprex’s platform technologies are designed to administer cancer-fighting genes by encapsulating them into nanoscale hollow spheres called nanovesicles, which are then administered intravenously and taken up by tumor cells where they express proteins that are missing or found in low quantities. The company’s lead product candidate, Oncoprex(TM) immunogene therapy for non-small cell lung cancer (“NSCLC”), has a multimodal mechanism of action whereby it interrupts cell signaling pathways that cause replication and proliferation of cancer cells, re-establishes pathways for apoptosis, or programmed cell death, in cancer cells, and modulates the immune response against cancer cells. Oncoprex has also been shown to block mechanisms that create drug resistance. For more information, visit the company’s website at www.Genprex.com.

NOTE TO INVESTORS: The latest news and updates relating to GNPX are available in the company’s newsroom at http://nnw.fm/GNPX

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

More News From tech.aseancoverage.com

China says US has 'weaponized' visas to target exchanges

Dec 6, 2019

BEIJING — China on Wednesday accused the U.S. of having "weaponized" the issuance of visas following the reported inability of a top Chinese space program official to obtain permission to travel to a key conference in Washington. Foreign Ministry spokeswoman Hua Chunying told reporters that the head of the Chinese delegation to the International Astronautical Congress wasn't able to obtain a visa following an Oct. 12 interview, making it difficult for Chinese representatives to attend important events at the meeting. Reports said the vice chairman of the China National Space Administration, Wu Yanhua, had planned to attend the congress. Hua...

China criticizes Apple for app that tracks Hong Kong police

Dec 6, 2019

HONG KONG — Apple became the latest company targeted for Chinese pressure over protests in Hong Kong after the ruling Communist Party's main newspaper criticized the tech giant Wednesday for a smartphone app that allows activists to report police movements. HKmap.live, designed by an outside supplier and available on Apple Inc.'s online store, "facilitates illegal behavior," the People's Daily said in a commentary. "Is Apple guiding Hong Kong thugs?" the newspaper said. Beijing has pressed companies including Hong Kong's Cathay Pacific Airways to take the government's side against the protests, which are in their fourth month. Apple didn't immediately respond...

Japan spacecraft releases rover to asteroid in last mission

Dec 6, 2019

TOKYO — Japan’s Hayabusa2 spacecraft released a small rover on Thursday that will land on the surface of an asteroid as part its final mission before heading back to Earth, Japan’s space agency said. The Minerva-II2 rover began a slow descent to the asteroid Ryugu, the Japan Aerospace Exploration Agency, or JAXA, said. Hayabusa2 arrived in the area in June 2018. It has collected soil samples and other data from the asteroid 300 million kilometers (180 million miles) from Earth in a series of missions aimed at obtaining clues to the origin of the solar system. The spacecraft released the...

NASA chief says security needed to explore space safely

Dec 6, 2019

TOKYO — The head of NASA says space security is necessary so that the United States, Japan and others can safely explore the moon and Mars. NASA Administrator Jim Bridenstine said Wednesday that gadgets using space technology have become indispensable parts of people's lives and their safety must be preserved. Japan and the U.S. have long cooperated in space science, including the ongoing International Space Station program. On Tuesday, NASA and the Japan Aerospace Exploration Agency, or JAXA, confirmed Japan's participation in America's lunar and Mars exploration projects, including an Artemis lunar mission. Bridenstine is in Japan to gain Japanese...

Japan briefs diplomats on Fukushima nuclear water concerns

Dec 6, 2019

TOKYO — Japan tried to reassure foreign diplomats Wednesday about safety at the crippled Fukushima nuclear plant amid concerns about massive amounts of treated but radioactive water stored in tanks. Diplomats from 22 countries and regions attended a briefing at the Foreign Ministry, where Japanese officials stressed the importance of combating rumors about safety at the plant, which was decimated by a 2011 earthquake and tsunami, while pledging transparency. The plant's operator, Tokyo Electric Power Co., or TEPCO, said last month that it would run out of storage space for the water in 2022, prompting South Korea to raise safety...

AseanCoverage is a next-gen news site focusing exclusively on online news from South East Asia.

Contact us: sales[at]aseancoverage.com